CPT code 36466 – Non-compounded foam sclerotherapy, multiple veins

Key Takeaways

CPT code 36466 covers foam sclerotherapy treating multiple incompetent veins or telangiectasia in one lower-extremity leg session; use 36465 for single-vein sessions.

Medicare classifies spider-vein sclerotherapy as cosmetic when performed for appearance only; medical necessity requires documented symptoms such as aching, swelling, or ulceration.

LT and RT laterality modifiers are required by most payers; modifier 76 applies when the same leg is retreated at a separate session.

Pabau’s claims management tools support clean-claim submission and real-time eligibility checks, reducing 36466 denials before they reach the payer.

CPT code 36466: official descriptor and what it covers

CPT code 36466 is defined by the American Medical Association as: Injection of non-compounded foam sclerosant, with or without ultrasound guidance, incompetent veins, multiple, including telangiectasia, venules, varicose veins, any diameter, lower extremity, single leg, including all treated veins that are accessory to the same saphenous trunk.

Three elements define what this code covers and excludes:

• Non-compounded foam only. The sclerosant must be a commercially manufactured, non-compounded foam agent. Physician-compounded polidocanol foam falls outside this descriptor and may not be reimbursable under 36466 depending on payer policy.
• Multiple vessels per session. “Multiple” distinguishes this code from 36465, which covers a single incompetent vein. Injecting two or more vessels in one sitting moves the claim to 36466.
• Single lower extremity per session. The descriptor is leg-specific. Bilateral treatment in the same session requires separate billing for each leg with the appropriate laterality modifier.

Understanding how medical billing works for procedural codes like 36466 starts with the descriptor: every payer edits their claim logic against it, and documentation gaps become denial reasons almost automatically.

Procedure description and clinical context

Sclerotherapy injects a chemical agent directly into a diseased vein, causing endothelial irritation and eventual fibrosis. The vessel shrinks and is reabsorbed over weeks. Foam sclerosants displace blood more effectively than liquid agents, which increases contact time with the vessel wall and reduces the volume needed per injection site.

CPT code 36466 applies when this technique treats telangiectasia (spider veins), reticular veins, or varicose veins in the lower extremity using a non-compounded foam formulation across multiple vessels. Clinical indications that support medical necessity include symptomatic venous insufficiency with documented aching, heaviness, swelling, or skin changes rather than cosmetic concerns alone.

CPT 36466 vs 36465: how to choose the right code

The single key distinction is vessel count per session. Use 36465 when one incompetent vein or telangiectasia cluster is treated; use CPT code 36466 when multiple vessels are injected in the same leg session.

A practical decision rule: if the operative note documents injections at more than one discrete vessel location in a single leg session, CPT code 36466 is the correct choice. Billing 36465 in that scenario is undercoding and leaves reimbursement on the table.

Adjacent vein codes: 36471, 36475, and the 3646x family

Sclerotherapy and vein ablation codes share a section of the surgery chapter. Selecting the wrong code is among the most common errors in phlebology billing.

The primary decision fork is agent type: non-compounded foam goes to 36465/36466, liquid sclerosant goes to 36470/36471, and thermal energy goes to 36475/36476. CPT code 36466 sits in the foam-plus-multiple position on that grid.

ICD-10 diagnosis codes to pair with CPT code 36466

Payers match the submitted ICD-10 code against their LCD to determine whether the procedure is medically necessary or cosmetic. The diagnosis drives coverage, so a mismatched or incomplete code is one of the fastest routes to a denial.

Specificity matters at the fourth and fifth character level: I83.009 (unspecified extremity) triggers audits more frequently than I83.012 (right leg) or I83.022 (left leg with inflammation). Use the most specific code supported by the clinical documentation.

Medicare coverage and LCD requirements for CPT code 36466

Medicare’s position on sclerotherapy is defined in CMS Coverage Article 58250 and the related Local Coverage Determinations issued by Medicare Administrative Contractors. Coverage is not uniform across all payer regions, and billers should verify the applicable MAC LCD before submitting.

The core Medicare rule: sclerotherapy for telangiectasia (spider veins) performed for cosmetic purposes only is explicitly non-covered. Coverage applies when the procedure is medically necessary to treat symptomatic venous disease, not appearance-related concerns. This distinction must appear in the documentation, not just in the coder’s intent.

Review medical billing compliance requirements for vein procedures before submitting claims to Medicare. The consequences of a cosmetic-exclusion denial extend beyond rejected claims into potential overpayment recovery audits.

Medicare coverage criteria summary

• Documented functional symptoms: aching, heaviness, leg fatigue, edema, skin changes, or ulceration attributable to venous disease
• Duplex ultrasound findings: reflux documented at the saphenofemoral or saphenopopliteal junction (duration and laterality noted)
• Conservative treatment trial: typically three to six months of graduated compression stockings (20-30 mmHg or greater), with compliance documented in the chart
• Physician attestation: note confirming functional impairment and that the procedure is performed to treat venous disease, not for cosmetic improvement

Medical necessity documentation requirements

Documentation failures are the primary reason CPT code 36466 claims fail on audit rather than on initial submission. The chart note needs to support medical necessity, not just record the procedure performed.

A complete superbill for a 36466 claim should include the encounter note, duplex ultrasound report, and a prior treatment record showing compression stocking compliance. Missing any one of these is the documentation equivalent of a missing modifier: the claim processes but returns a denial upon review.

• History of present illness: document symptom onset, duration, and functional impact (e.g., unable to stand for prolonged periods due to leg aching)
• Physical examination: describe distribution and severity of varicosities or telangiectasia, presence of edema, skin changes
• Diagnostic imaging: reference the duplex ultrasound report with reflux measurements; note which veins were assessed
• Conservative treatment record: date compression therapy was initiated, stocking grade prescribed, and patient compliance noted at each interval visit
• Procedure note: identify each vessel treated, sclerosant used (brand and concentration), volume injected, and technique (foam vs liquid)

Manage vein procedure billing from chart note to claim

Pabau’s claims management tools help vascular and phlebology practices submit clean 36466 claims with the documentation payers need. See how the platform handles coding workflows, eligibility checks, and denial tracking.

Book a demo

Modifiers for CPT code 36466

CPT code 36466 is leg-specific by descriptor, so modifiers communicate laterality and session context. Missing a required modifier is among the top five denial reasons for this code family.

For bilateral treatment, verify individual payer preference before billing: Medicare and many commercial plans accept modifier 50 on a single line item, while some managed care contracts require two separate line items with LT and RT on each.

2025-2026 Medicare fee schedule rates for CPT code 36466

Medicare reimbursement for CPT code 36466 is calculated from the CMS Physician Fee Schedule lookup tool. Rates differ between facility settings (outpatient hospital, ASC) and non-facility settings (office). The values below reflect the 2025 national unadjusted amounts; apply the applicable geographic practice cost index for your locality.

Use the FastRVU lookup tool to retrieve current Work, Practice Expense, and Malpractice RVU values for 36466 and apply your locality conversion factor. Commercial payer rates vary by contract and are typically a percentage of the Medicare fee schedule, ranging from 100% to 180% for vein procedures depending on the market.

Billing CPT code 36466 with ultrasound guidance (76942)

CPT code 36466 includes the phrase “with or without ultrasound guidance” in its descriptor, which creates a bundling trap many practices miss. Because the descriptor already contemplates guidance, ultrasound guidance is not automatically separately billable alongside 36466.

However, separate billing of 76942 (ultrasound guidance for needle placement, with permanent recording and reporting) may be permitted when the guidance is distinctly documented as a separate and necessary service. Payer bundling edits vary: some MACs and commercial plans bundle 76942 into 36466 and will not pay separately; others will pay 76942 separately when the documentation requirements are met.

Requirements to support separate 76942 billing

• Permanent recording: images must be stored in the medical record (not just used and discarded)
• Written interpretation: a separate interpretation report must be generated and signed by the supervising physician
• Clinical rationale: the note must explain why real-time imaging guidance was necessary (e.g., deep or anatomically complex vessel location)
• Payer verification: confirm the specific payer’s bundling edit before billing; never assume 76942 is payable with 36466 without checking the payer contract and applicable NCCI edits

Practices submitting 76942 alongside 36466 without payer verification and documentation are among the most frequent recipients of overpayment demand letters in phlebology audits.

Global period and unbundling rules

CPT code 36466 carries a -day global period according to CMS global period indicators. This means no pre-operative or post-operative services are bundled into the procedure payment: office visits related to the condition on the day of service before the procedure, and follow-up visits after the procedure, may be billed separately when documented as distinct services.

Despite the 0-day global, unbundling risks remain. Evaluation and management services on the same day as 36466 require modifier 25 on the E/M code and documentation that the visit was a significant, separately identifiable service unrelated to the immediate decision to perform the procedure. Billing a follow-up visit the same day as the sclerotherapy session without modifier 25 is a common audit trigger.

Common claim denial reasons for CPT code 36466 and how to resolve them

Tracking denial patterns in healthcare billing is more valuable than responding to individual rejections. For CPT code 36466, six denial types account for the majority of rejected claims.

Submitting through Pabau’s Claim.MD clearinghouse integration catches formatting errors, modifier omissions, and ICD-10 mismatches before the claim reaches the payer, reducing the volume of 36466 denials that require manual appeal. The integration supports real-time eligibility verification and electronic remittance advice, so practices see denial reasons on the same day rather than weeks after submission.

For practices managing a high volume of vein procedure denials, Pabau’s claims management software provides denial tracking, appeal workflow tools, and ERA posting to identify the codes and modifiers generating the most rejections across your payer mix.

Conclusion

CPT code 36466 is a straightforward code with an outsized denial rate caused by documentation gaps rather than clinical complexity. The cosmetic exclusion, missing compression trial records, and absent laterality modifiers account for the majority of rejections.

Pabau’s clean claim workflows and Claim.MD clearinghouse integration help phlebology and vascular practices catch these errors before submission, reducing the time spent on appeals and getting 36466 claims paid on first pass. Book a demo to see how the platform handles vein procedure billing end to end.

Continue your research

Need to verify eligibility before a sclerotherapy session? Insurance eligibility verification explains how to check patient coverage and reduce upfront denials for vein procedures.

Want to understand what makes a claim pay on the first submission? Revenue cycle management fundamentals walks through the end-to-end process from charge capture to ERA posting.

Working through a high denial rate across your vein procedure codes? Denial codes in medical billing explains the most common CARC and RARC codes and what each one requires in response.

Frequently Asked Questions